(Q28165686)

English

No label defined

scientific article (publication date: 15 October 2003)

In more languages

Statements

scholarly article

0 references

The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial (English)

0 references

0 references

Maria Krzemińska-Pakuła

7

object named as

Maria Krzeminska-Pakula

0 references

Harvey D. White

9

object named as

Harvey D White

0 references

author name string

Marc Cohen

1

0 references

Gian Franco Gensini

2

0 references

Frans Maritz

3

0 references

Enrique P Gurfinkel

4

0 references

Kurt Huber

5

0 references

Ari Timerman

6

0 references

Nicolas Danchin

8

0 references

Jose Santopinto

10

0 references

Frederique Bigonzi

11

0 references

Carole Hecquet

12

0 references

Luc Vittori

13

0 references

language of work or name

0 references

publication date

15 October 2003

0 references

Journal of the American College of Cardiology

0 references

42

0 references

8

0 references

1348-56

0 references

Management of acute myocardial infarction in patients presenting with ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Consequences of overutilization and underutilization of thrombolytic therapy in clinical practice. TRACE Study Group. TRAndolapril Cardiac Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with tirofiban and enoxaparin in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using [...]

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The TETAMI trial: the safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in the treatment of acute myocardial infarction for patients not thrombolyzed: methods and design

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional Variation across the United States in the Management of Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myocardial infarction in the elderly: differences by age

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary angioplasty and selection bias inpatients presenting late (>12 h) after onset of chest pain and ST elevation myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUS

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901040-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(03)01040-4

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28165686&oldid=2063365546"